Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
14 "Sunghwan Suh"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Diabetes, obesity and metabolism
Glucocorticoid-Induced Hyperglycemia: A Neglected Problem
Jung-Hwan Cho, Sunghwan Suh
Endocrinol Metab. 2024;39(2):222-238.   Published online March 27, 2024
DOI: https://doi.org/10.3803/EnM.2024.1951
  • 2,382 View
  • 130 Download
AbstractAbstract PDFPubReader   ePub   
Glucocorticoids provide a potent therapeutic response and are widely used to treat a variety of diseases, including coronavirus disease 2019 (COVID-19) infection. However, the issue of glucocorticoid-induced hyperglycemia (GIH), which is observed in over one-third of patients treated with glucocorticoids, is often neglected. To improve the clinical course and prognosis of diseases that necessitate glucocorticoid therapy, proper management of GIH is essential. The key pathophysiology of GIH includes systemic insulin resistance, which exacerbates hepatic steatosis and visceral obesity, as well as proteolysis and lipolysis of muscle and adipose tissue, coupled with β-cell dysfunction. For patients on glucocorticoid therapy, risk stratification should be conducted through a detailed baseline evaluation, and frequent glucose monitoring is recommended to detect the onset of GIH, particularly in high-risk individuals. Patients with confirmed GIH who require treatment should follow an insulin-centered regimen that varies depending on whether they are inpatients or outpatients, as well as the type and dosage of glucocorticoid used. The ideal strategy to maintain normoglycemia while preventing hypoglycemia is to combine basal-bolus insulin and correction doses with a continuous glucose monitoring system. This review focuses on the current understanding and latest evidence concerning GIH, incorporating insights gained from the COVID-19 pandemic.
Close layer
Editorial
Diabetes, obesity and metabolism
The Characteristics and Risk of Mortality in the Elderly Korean Population
Sunghwan Suh
Endocrinol Metab. 2023;38(5):522-524.   Published online October 23, 2023
DOI: https://doi.org/10.3803/EnM.2023.502
  • 965 View
  • 53 Download
PDFPubReader   ePub   
Close layer
Original Articles
Diabetes, obesity and metabolism
Intake of Fruit and Glycemic Control in Korean Patients with Diabetes Mellitus Using the Korea National Health and Nutrition Examination Survey
Eunju Yoon, Ji Cheol Bae, Sunghwan Suh
Endocrinol Metab. 2023;38(5):538-544.   Published online August 8, 2023
DOI: https://doi.org/10.3803/EnM.2023.1730
  • 2,217 View
  • 117 Download
  • 1 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
Despite the well-recognized health benefits of fresh fruit consumption, there is still substantial uncertainty about its potential effects on glycemic control in patients with type 2 diabetes mellitus (T2DM).
Methods
We examined the association of fresh fruit consumption and glycemic control in patients with T2DM using data from the 6th Korea National Health and Nutrition Examination Survey. The study sample was divided into three groups based on weekly fruit consumption frequency for the analysis.
Results
Patients with the highest fruit intake were older than those in the other two groups, and women were more likely to consume fruits in general. Being a current smoker and weekly alcohol intake also showed negative correlations according to the fruit intake tertiles. Fruit consumption was positively correlated with better hemoglobin A1c (HbA1c) levels. Moreover, patients in the highest tertile of fruit intake were 3.48 times more likely to be in good glycemic control defined as HbA1c <7%.
Conclusion
We observed that fruit consumption can be helpful in glycemic control in Korean patients with T2DM.

Citations

Citations to this article as recorded by  
  • The Relationship between Alcohol Consumption and Diabetes in Korean Adults
    Gi Tae Kim, Jae Woong Sull
    Biomedical Science Letters.2023; 29(3): 159.     CrossRef
Close layer
Diabetes, obesity and metabolism
Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study
Ji Min Han, Jung Hwan Cho, Hye In Kim, Sunghwan Suh, Yu-Ji Lee, Jung Won Lee, Kwang Min Kim, Ji Cheol Bae
Endocrinol Metab. 2023;38(4):418-425.   Published online July 12, 2023
DOI: https://doi.org/10.3803/EnM.2023.1729
  • 1,343 View
  • 80 Download
AbstractAbstract PDFPubReader   ePub   
Background
Fatty liver is associated with increased risk of developing type 2 diabetes. We aimed to evaluate whether the severity of hepatic steatosis is associated with incident diabetes.
Methods
We conducted a longitudinal analysis using data from 1,798 participants who underwent a comprehensive health checkup and abdominal computed tomography (CT). We assessed the association between baseline liver attenuation value on non-contrast CT images and risk of incident diabetes. All the participants were categorized into three groups based on the baseline liver attenuation value on non-contrast CT images: without hepatic steatosis (>57 Hounsfield unit [HU]), mild hepatic steatosis (41–57 HU), and moderate to severe hepatic steatosis (≤40 HU).
Results
During a median follow-up period of 5 years, 6.0% of the study participants progressed to diabetes. The incidence of diabetes was 17.3% in the moderate to severe hepatic steatosis group, 9.0% in the mild steatosis group, and 2.9% in those without hepatic steatosis. In a multivariate adjustment model, as compared with participants without hepatic steatosis, those with moderate to severe steatosis had a hazard ratio (HR) of 3.24 (95% confidence interval [CI], 1.64 to 4.2) for the development of diabetes, and those in the mild steatosis group had a HR of 2.33 (95% CI, 1.42 to 3.80). One standard deviation decrease in mean CT attenuation values of the liver was associated with a 40% increase in the development of diabetes (multivariate adjusted HR, 1.40; 95% CI, 1.2 to 1.63).
Conclusion
We found a positive association between severity of hepatic steatosis and risk of incident diabetes. Greater severity of steatosis was associated with a higher risk of incident diabetes.
Close layer
Corrigendum
Miscellaneous
Corrigendum: Affiliation Correction. Development and Validation of a Risk Scoring System Derived from Meta-Analyses for Papillary Thyroid Cancer
Sunghwan Suh, Tae Sik Goh, Yun Hak Kim, Sae-Ock Oh, Kyoungjune Pak, Ju Won Seok, In Joo Kim
Endocrinol Metab. 2023;38(2):287.   Published online April 27, 2023
DOI: https://doi.org/10.3803/EnM.2023.202
Corrects: Endocrinol Metab 2020;35(2):435
  • 1,042 View
  • 66 Download
PDFPubReader   ePub   
Close layer
Special Articles
Miscellaneous
Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society
Hyemi Kwon, Eun Roh, Chang Ho Ahn, Hee Kyung Kim, Cheol Ryong Ku, Kyong Yeun Jung, Ju Hee Lee, Eun Heui Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Jun Sung Moon, Jin Hwa Kim, Mi-kyung Kim, The Committee of Clinical Practice Guideline of the Korean Endocrine Society
Endocrinol Metab. 2022;37(6):839-850.   Published online December 26, 2022
DOI: https://doi.org/10.3803/EnM.2022.1627
  • 3,943 View
  • 331 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Immune checkpoint inhibitors (ICIs) including an anti-cytotoxic T-lymphocyte-associated antigen 4 inhibitor, anti-programmed cell death protein 1 (PD-1) inhibitors, and anti-PD-ligand 1 inhibitors are representative therapeutics for various malignancies. In oncology, the application of ICIs is currently expanding to a wider range of malignancies due to their remarkable clinical outcomes. ICIs target immune checkpoints which suppress the activity of T-cells that are specific for tumor antigens, thereby allowing tumor cells to escape the immune response. However, immune checkpoints also play a crucial role in preventing autoimmune reactions. Therefore, ICIs targeting immune checkpoints can trigger various immune-related adverse events (irAEs), especially in endocrine organs. Considering the endocrine organs that are frequently involved, irAEs associated endocrinopathies are frequently life-threatening and have unfavorable clinical implications for patients. However, there are very limited data from large clinical trials that would inform the development of clinical guidelines for patients with irAEs associated endocrinopathies. Considering the current clinical situation, in which the scope and scale of the application of ICIs are increasing, position statements from clinical specialists play an essential role in providing the appropriate recommendations based on both medical evidence and clinical experience. As endocrinologists, we would like to present precautions and recommendations for the management of immune-related endocrine disorders, especially those involving the adrenal, thyroid, and pituitary glands caused by ICIs.

Citations

Citations to this article as recorded by  
  • Pembrolizumab plus lenvatinib for radically unresectable or metastatic renal cell carcinoma in the Japanese population
    Ryo Fujiwara, Takeshi yuasa, kenichi kobayashi, tetsuya yoshida, susumu kageyama
    Expert Review of Anticancer Therapy.2023; 23(5): 461.     CrossRef
  • Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review
    Won Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, Hwa Young Ahn
    Endocrinology and Metabolism.2023; 38(6): 750.     CrossRef
Close layer
Miscellaneous
COVID-19 Vaccination for Endocrine Patients: A Position Statement from the Korean Endocrine Society
Cheol Ryong Ku, Kyong Yeun Jung, Chang Ho Ahn, Jun Sung Moon, Ju Hee Lee, Eun Heui Kim, Hyemi Kwon, Hee Kyung Kim, Sunghwan Suh, Sangmo Hong, Jeonghoon Ha, Eun Roh, Jin Hwa Kim, Mi-kyung Kim, the Committee of Clinical Practice Guideline of the Korean Endocrine Society
Endocrinol Metab. 2021;36(4):757-765.   Published online August 17, 2021
DOI: https://doi.org/10.3803/EnM.2021.404
  • 10,834 View
  • 421 Download
  • 20 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   ePub   
Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most countries, both mRNA and DNA vaccines have been administered, and their side effects have also been reported. The clinical course of COVID-19 and the effects of vaccination against COVID-19 are both influenced by patients’ health status and involve a systemic physiological response. In view of the systemic function of endocrine hormones, endocrine disorders themselves and the therapeutics used to treat them can influence the outcomes of vaccination for COVID-19. However, there are very limited data to support the development of clinical guidelines for patients with specific medical backgrounds based on large clinical trials. In the current severe circumstances of the COVID-19 pandemic, position statements made by clinical specialists are essential to provide appropriate recommendations based on both medical evidence and clinical experiences. As endocrinologists, we would like to present the medical background of COVID-19 vaccination, as well as precautions to prevent the side effects of COVID-19 vaccination in patients with specific endocrine disorders, including adrenal insufficiency, diabetes mellitus, osteoporosis, autoimmune thyroid disease, hypogonadism, and pituitary disorders.

Citations

Citations to this article as recorded by  
  • COVID-19 mRNA vaccine may trigger subacute thyroiditis
    Mehmet Sözen, Ömercan Topaloğlu, Berrin Çetinarslan, Alev Selek, Zeynep Cantürk, Emre Gezer, Damla Köksalan, Taner Bayraktaroğlu
    Human Vaccines & Immunotherapeutics.2024; 17(12): 5120.     CrossRef
  • The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands
    C. Ouaddouh, J.W. Duijster, T. Lieber, F.P.A.M. van Hunsel
    Expert Opinion on Drug Safety.2024; 23(3): 323.     CrossRef
  • Thyroid dysfunction in COVID-19
    David Tak Wai Lui, Chi Ho Lee, Yu Cho Woo, Ivan Fan Ngai Hung, Karen Siu Ling Lam
    Nature Reviews Endocrinology.2024; 20(6): 336.     CrossRef
  • Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination
    Hyeyeon Moon, Sunghwan Suh, Mi Kyoung Park
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Prior immunization status of COVID-19 patients and disease severity: A multicenter retrospective cohort study assessing the different types of immunity
    Javaria Aslam, Faisal Shahzad Khan, Muhammad Talha Haris, Hewad Hewadmal, Maryam Khalid, Mohammad Y. Alshahrani, Qurrat-ul-ain Aslam, Irrum Aneela, Urooj Zafar
    Vaccine.2023; 41(2): 598.     CrossRef
  • Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study
    Eu Jeong Ku, Keeho Song, Kyoung Min Kim, Gi Hyeon Seo, Soon Jib Yoo
    Endocrinology and Metabolism.2023; 38(2): 253.     CrossRef
  • Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
    Jeonghoon Ha, Kyoung Min Kim, Dong-Jun Lim, Keeho Song, Gi Hyeon Seo
    Journal of Clinical Medicine.2023; 12(14): 4799.     CrossRef
  • Inactivated SARS-CoV-2 vaccination does not disturb the clinical course of Graves’ disease: An observational cohort study
    Shichen Xu, Huixin Yu, Xian Cheng, Jing Wu, Jiandong Bao, Li Zhang
    Vaccine.2023; 41(38): 5648.     CrossRef
  • Adrenal Crisis Associated With COVID-19 Vaccination in Patients With Adrenal Insufficiency
    Yukako Kurematsu, Takako Mohri, Sadanori Okada, Yutaka Takahashi
    JCEM Case Reports.2023;[Epub]     CrossRef
  • Adverse Events Associated with COVID-19 Vaccination in Adolescents with Endocrinological Disorders: A Cross-Sectional Study
    İbrahim Mert Erbaş, İrem Ceren Erbaş, Gözde Akın Kağızmanlı, Kübra Yüksek Acinikli, Özge Besci, Korcan Demir, Ece Böber, Nurşen Belet, Ayhan Abacı
    Journal of Clinical Research in Pediatric Endocrinology.2023; 15(3): 248.     CrossRef
  • Neue Aspekte der Glukokortikoidsubstitution bei Nebennierenrindeninsuffizienz
    Tina Kienitz, Gesine Meyer
    Der Internist.2022; 63(1): 12.     CrossRef
  • Endocrine Follow-up During Post-Acute COVID-19: Practical Recommendations Based on Available Clinical Evidence
    Rimesh Pal, Ameya Joshi, Sanjay K. Bhadada, Mainak Banerjee, Suresh Vaikkakara, Satinath Mukhopadhyay
    Endocrine Practice.2022; 28(4): 425.     CrossRef
  • Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study
    Xi Xiong, Carlos King Ho Wong, Ivan Chi Ho Au, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Celine Sze Ling Chui, Esther Wai Yin Chan, Franco Wing Tak Cheng, Kristy Tsz Kwan Lau, Chi Ho Lee, Yu Cho Woo, David Tak Wai Lui, Ian Chi Kei Wong
    Thyroid.2022; 32(5): 505.     CrossRef
  • The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine
    Mihaela Popescu, Adina Ghemigian, Corina Maria Vasile, Andrei Costache, Mara Carsote, Alice Elena Ghenea
    Diagnostics.2022; 12(4): 960.     CrossRef
  • Adrenal Crisis Secondary to COVID-19 Vaccination in a Patient With Hypopituitarism
    Nikolina Markovic, Anila Faizan, Chirag Boradia, Sridhar Nambi
    AACE Clinical Case Reports.2022; 8(4): 171.     CrossRef
  • The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
    LingHong Huang, ZhengRong Jiang, JingXiong Zhou, YuPing Chen, HuiBin Huang
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Osteoporosis in Patients With Respiratory Diseases
    Yue Ma, Shui Qiu, Renyi Zhou
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology
    Ach Taieb, El Euch Mounira
    Vaccines.2022; 10(12): 2004.     CrossRef
  • Forty Years Together, New Leap Forward! The 40th Anniversary of the Korean Endocrine Society
    Jong Chul Won, Ki-Hyun Baek
    Endocrinology and Metabolism.2022; 37(6): 851.     CrossRef
  • No need of glucocorticoid dose adjustment in patients with adrenal insufficiency before COVID-19 vaccine
    Tania Pilli, Cristina Dalmiglio, Gilda Dalmazio, Alfonso Sagnella, Raffaella Forleo, Lucia Brilli, Fabio Maino, Cristina Ciuoli, Maria Grazia Castagna
    European Journal of Endocrinology.2022; 187(1): K7.     CrossRef
  • Diabetes and COVID-19 Vaccination
    Hae Dong Choi, Jun Sung Moon
    The Journal of Korean Diabetes.2021; 22(4): 221.     CrossRef
Close layer
Original Article
Clinical Study
Development and Validation of a Risk Scoring System Derived from Meta-Analyses of Papillary Thyroid Cancer
Sunghwan Suh, Tae Sik Goh, Yun Hak Kim, Sae-Ock Oh, Kyoungjune Pak, Ju Won Seok, In Joo Kim
Endocrinol Metab. 2020;35(2):435-442.   Published online June 24, 2020
DOI: https://doi.org/10.3803/EnM.2020.35.2.435
Correction in: Endocrinol Metab 2023;38(2):287
  • 5,790 View
  • 132 Download
  • 3 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Background
The aim of this study was to develop a scoring system to stratify the risk of papillary thyroid cancer (PTC) and to select the proper management.
Methods
We performed a systematic search of MEDLINE and Embase. Data regarding patients’ prognoses were obtained from the included studies. Odds ratios (ORs) with statistical significance were extracted from the publications. To generate a risk scoring system (RSS), ORs were summed (RSS1), and summed after natural-logarithmic transformation (RSS2). RSS1 and RSS2 were compared to the eighth edition of the American Joint Committee on Cancer (AJCC) staging system and the 2015 American Thyroid Association (ATA) guidelines for thyroid nodules and differentiated thyroid carcinoma.
Results
Five meta-analyses were eligible for inclusion in the study. Eight variables (sex, tumour size, extrathyroidal extension, BRAF mutation, TERT mutation, histologic subtype, lymph node metastasis, and distant metastasis) were included. RSS1 was the best of the analysed models.
Conclusion
We developed and validated a new RSS derived from previous meta-analyses for patients with PTC. This RSS seems to be superior to previously published systems.

Citations

Citations to this article as recorded by  
  • Investigating 18F-FDG PET/CT Parameters as Prognostic Markers for Differentiated Thyroid Cancer: A Systematic Review
    Hongxi Wang, Hongyuan Dai, Qianrui Li, Guohua Shen, Lei Shi, Rong Tian
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Impact of Multifocality on the Recurrence of Papillary Thyroid Carcinoma
    Joohyun Woo, Hyeonkyeong Kim, Hyungju Kwon
    Journal of Clinical Medicine.2021; 10(21): 5144.     CrossRef
Close layer
Review Article
Glucocorticoid-Induced Diabetes Mellitus: An Important but Overlooked Problem
Sunghwan Suh, Mi Kyoung Park
Endocrinol Metab. 2017;32(2):180-189.   Published online May 29, 2017
DOI: https://doi.org/10.3803/EnM.2017.32.2.180
  • 16,159 View
  • 622 Download
  • 113 Web of Science
  • 120 Crossref
AbstractAbstract PDFPubReader   ePub   

Glucocorticoids are widely used as potent anti-inflammatory and immunosuppressive drugs to treat a wide range of diseases. However, they are also associated with a number of side effects, including new-onset hyperglycemia in patients without a history of diabetes mellitus (DM) or severely uncontrolled hyperglycemia in patients with known DM. Glucocorticoid-induced diabetes mellitus (GIDM) is a common and potentially harmful problem in clinical practice, affecting almost all medical specialties, but is often difficult to detect in clinical settings. However, scientific evidence is lacking regarding the effects of GIDM, as well as strategies for prevention and treatment. Similarly to nonsteroid-related DM, the principles of early detection and risk factor modification apply. Screening for GIDM should be considered in all patients treated with medium to high doses of glucocorticoids. Challenges in the management of GIDM stem from wide fluctuations in postprandial hyperglycemia and the lack of clearly defined treatment protocols. Together with lifestyle measures, hypoglycemic drugs with insulin-sensitizing effects are indicated. However, insulin therapy is often unavoidable, to the point that insulin can be considered the drug of choice. The treatment of GIDM should take into account the degree and pattern of hyperglycemia, as well as the type, dose, and schedule of glucocorticoid used. Moreover, it is essential to instruct the patient and/or the patient's family about how to perform the necessary adjustments. Prospective studies are needed to answer the remaining questions regarding GIDM.

Citations

Citations to this article as recorded by  
  • COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms
    Mohsen Pourazizi, Atousa Hakamifard, Alireza Peyman, Rasoul Mohammadi, Shakiba Dehghani, Najmeh Tavousi, Nastaran‐Sadat Hosseini, Hamed Azhdari Tehrani, Bahareh Abtahi‐Naeini
    Parasite Immunology.2024;[Epub]     CrossRef
  • Drug-induced hyperglycemia and diabetes
    Marie-Anne Heurtebize, Jean-Luc Faillie
    Therapies.2024; 79(2): 221.     CrossRef
  • Immunosuppression in solid organ–transplant recipients and impact on nutrition support
    Nicole K. Wilson, Ann D. Kataria
    Nutrition in Clinical Practice.2024; 39(1): 109.     CrossRef
  • Incidence and Characteristics of the Hyperosmolar Hyperglycemic State: A Danish Cohort Study
    Emilie V. Rosager, Amalia Lærke K. Heltø, Cathrine U. Fox Maule, Lennart Friis-Hansen, Janne Petersen, Finn E. Nielsen, Steen B. Haugaard, Rasmus Gregersen
    Diabetes Care.2024; 47(2): 272.     CrossRef
  • Cortisol levels across the lifespan in common marmosets (Callithrix jacchus)
    Matthew Lopez, Amaya Seidl, Kimberley A. Phillips
    American Journal of Primatology.2024;[Epub]     CrossRef
  • Belimumab in a Patient with Systemic Lupus Erythematosus with Juvenile Onset and Steroid-induced Diabetes: Clinical Case
    Maria I. Kaleda, Irina P. Nikishina, Alesya V. Firsa
    Current Pediatrics.2024; 22(6): 546.     CrossRef
  • Optimal initial insulin dosage for managing steroid-induced hyperglycemia in hospitalized COVID-19 patients: A retrospective single-center study
    Nuttavadee Ketaroonrut, Sasisopin Kiertiburanakul, Chutintorn Sriphrapradang
    SAGE Open Medicine.2024;[Epub]     CrossRef
  • Extended-Release Versus Immediate-Release Triamcinolone Acetonide in Patients Who Have Knee Osteoarthritis and Type 2 Diabetes Mellitus
    Andrew I. Spitzer, Helena W. Rodbard, Sheikh Usman Iqbal, Masato Nakazawa, Mary DiGiorgi, Roy Winston
    The Journal of Arthroplasty.2024;[Epub]     CrossRef
  • Important aspects of carbohydrate metabolism disorders development in hematology/oncology patients during therapy with glucocorticosteroids: a review of the literature
    N. T. Vatutin, E. V. Sklyannaya, V. V. Gribov
    Oncohematology.2024; 19(2): 118.     CrossRef
  • The safety and use of perioperative dexamethasone in the perioperative management of primary sporadic supratentorial meningiomas
    Felix Arlt, Alim Emre Basaran, Markus Vogel, Martin Vychopen, Clemens Seidel, Alonso Barrantes-Freer, Erdem Güresir, Johannes Wach
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial
    Philip Ambery, Grzegorz Zajac, Joachim Almquist, Susanne Prothon, Carol Astbury, Mary N. Brown, Szilard Nemes, Joselyne Nsabimana, Karl Edman, Lisa Öberg, Matti Lepistö, Goran Edenro, Inken Dillmann, Suman Mitra, Graham Belfield, Christina Keen, Tim Heise
    British Journal of Clinical Pharmacology.2024;[Epub]     CrossRef
  • Continuous glucose monitoring profile in COVID-19 patients with and without diabetes receiving methylprednisolone
    Xingxing He, Guangchen Duan, Jingyi Lu, Yaxin Wang, Jinghao Cai, Yiqing Tong, Wei Wu, Xiaojing Ma, Qiming Feng, Jian Zhou
    Endocrine.2024;[Epub]     CrossRef
  • Sars-Cov2 Induced Biochemical Mechanisms in Liver Damage and Intestinal Lesions
    Liudmila V. Spirina, Vladimir N. Masunov, Denis A. Dyakov, Olga E. Akbasheva, Amina Y. Kebekbayeva, Igor Yu. Shuvalov, Nadezhda V. Masunova, Irina V. Kovaleva, Yumzhana Dagbaeva
    Indian Journal of Clinical Biochemistry.2023; 38(4): 437.     CrossRef
  • Mouse Pancreatic Peptide Hormones Probed at the Sub-Single-Islet Level: The Effects of Acute Corticosterone Treatment
    Aleksandra Antevska, Connor C. Long, Samuel D. Dupuy, J. Jason Collier, Michael D. Karlstad, Thanh D. Do
    Journal of Proteome Research.2023; 22(1): 235.     CrossRef
  • Type 1 and other types of diabetes mellitus in the perioperative period. What the anaesthetist should know
    Robert van Wilpe, Abraham H. Hulst, Sarah.E. Siegelaar, J. Hans DeVries, Benedikt Preckel, Jeroen Hermanides
    Journal of Clinical Anesthesia.2023; 84: 111012.     CrossRef
  • Continuous Glucose Monitoring of Steroid-Induced Hyperglycemia in Patients With Dermatologic Diseases
    Monika Kleinhans, Lea Jessica Albrecht, Sven Benson, Dagmar Fuhrer, Joachim Dissemond, Susanne Tan
    Journal of Diabetes Science and Technology.2023; : 193229682211479.     CrossRef
  • The Effects of Daily Prednisone and Tocilizumab on Hemoglobin A1c During the Treatment of Giant Cell Arteritis
    Naomi J. Patel, Veronica Tozzo, John M. Higgins, John H. Stone
    Arthritis & Rheumatology.2023; 75(4): 586.     CrossRef
  • Characterization, evolution and risk factors of diabetes and prediabetes in a pediatric cohort of renal and liver transplant recipients
    Sophie Welsch, Virginie Mailleux, Priscilla le Hardy de Beaulieu, Nadejda Ranguelov, Nathalie Godefroid, Annie Robert, Xavier Stephenne, Isabelle Scheers, Raymond Reding, Etienne M. Sokal, Philippe A. Lysy
    Frontiers in Pediatrics.2023;[Epub]     CrossRef
  • The safety of perioperative dexamethasone with antiemetic dosage in surgical patients with diabetes mellitus: a systematic review and meta-analysis
    Qian-Yun Pang, Jing-Yun Wang, Xiao-Long Liang, Yan Jiang, Hong-Liang Liu
    Perioperative Medicine.2023;[Epub]     CrossRef
  • Link between Blood Cell-Associated Inflammatory Indices and Chemotherapy-Induced Hyperglycemia in Women Affected with Breast Cancer: Clinical Studies
    Krishna Prasad, Suresh Rao, Sanath Kumar Hegde, Thomas George, Rhea Katherine D'souza, Sucharitha Suresh, Manjeshwar Shrinath Baliga
    South Asian Journal of Cancer.2023; 12(02): 118.     CrossRef
  • Hyperglycemia and Glycemic Variability Associated with Glucocorticoids in Women without Pre-Existing Diabetes Undergoing Neoadjuvant or Adjuvant Taxane Chemotherapy for Early-Stage Breast Cancer
    Dana Mahin, Sayeh Moazami Lavasani, Leon Cristobal, Niki Tank Patel, Mina Sedrak, Daphne Stewart, James Waisman, Yuan Yuan, Wai Yu, Raynald Samoa, Nora Ruel, Susan E. Yost, Hayley Lee, Sung Hee Kil, Joanne E. Mortimer
    Journal of Clinical Medicine.2023; 12(5): 1906.     CrossRef
  • Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats
    Priscila L. Zimath, Milena S. Almeida, Maciel A. Bruxel, Alex Rafacho
    Biochemical Pharmacology.2023; 210: 115486.     CrossRef
  • Regeneration of an infected skin wound under conditions of experimental steroid hyperglycemia
    L. A. Balykova, V. I. Inchina, T. V. Tarasova, D. A. Khaydar, L. M. Mosina, I. V. Saushev, A. V. Kuchuk, A. Mutvakel, I. V. Begoulov, R. S. Tarasov, P. V. Ageev, D. S. Ovchenkov
    Research and Practical Medicine Journal.2023; 10(1): 90.     CrossRef
  • Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
    Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
    International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
  • Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
    Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
    Endocrinology and Metabolism.2023; 38(2): 245.     CrossRef
  • Zein nanoparticles as oral carrier for mometasone furoate delivery
    Priscila Zimath, Soraia Pinto, Sofia Dias, Alex Rafacho, Bruno Sarmento
    Drug Delivery and Translational Research.2023; 13(11): 2948.     CrossRef
  • Impact of Diabetes in COVID-19 Associated Mucormycosis and its Management: A Non-Systematic Literature Review
    Muhammed Rashid, Asha K. Rajan, Girish Thunga, Vishal Shanbhag, Sreedharan Nair
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
    Abdulla Ahmed, Kriss Kania, Hebba Abdul Rahim, Salaheldin Ahmed, Göran Rådegran
    ESC Heart Failure.2023; 10(4): 2427.     CrossRef
  • Part II: Interactive case: Drug‐induced endocrine disorders
    Amy C. Donihi
    JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2023; 6(6): 663.     CrossRef
  • Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
    Riccardo Pofi, Giorgio Caratti, David W Ray, Jeremy W Tomlinson
    Endocrine Reviews.2023; 44(6): 975.     CrossRef
  • Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis
    Yu-Jih Su, Hui-Ming Chen, Tien-Ming Chan, Tien-Tsai Cheng, Shan-Fu Yu, Jia-Feng Chen, Chun-Yu Lin, Chung-Yuan Hsu
    RMD Open.2023; 9(3): e003045.     CrossRef
  • The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis
    Vasileios Giannopapas, Lina Palaiodimou, Dimitrios Kitsos, Georgia Papagiannopoulou, Konstantina Stavrogianni, Athanasios Chasiotis, Maria Kosmidou, John S. Tzartos, George P. Paraskevas, Daphne Bakalidou, Georgios Tsivgoulis, Sotirios Giannopoulos
    Journal of Clinical Medicine.2023; 12(15): 4948.     CrossRef
  • Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities
    Mihaela Simona Popoviciu, Lorena Paduraru, Raluca Marinela Nutas, Alexandra Maria Ujoc, Galal Yahya, Kamel Metwally, Simona Cavalu
    International Journal of Molecular Sciences.2023; 24(16): 12676.     CrossRef
  • Usefulness of Indian Diabetes Risk Score in Predicting Treatment-Induced Hyperglycemia in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
    Krishna Prasad, Sanath Hegde, Suresh Rao, Rhea Katherine D'souza, Thomas George, Manjeshwar Shrinath Baliga, Sucharitha Suresh
    South Asian Journal of Cancer.2023;[Epub]     CrossRef
  • The inverse association between DNA gaps and HbA1c levels in type 2 diabetes mellitus
    Jirapan Thongsroy, Apiwat Mutirangura
    Scientific Reports.2023;[Epub]     CrossRef
  • The effect of different types of oral or intravenous corticosteroids on capillary blood glucose levels in hospitalized inpatients with and without diabetes
    Vaishali Limbachia, Ian Nunney, Daniel J. Page, Hannah A. Barton, Leena K. Patel, Georgia N. Thomason, Stephan L. Green, Kieran F.J. Lewis, Ketan Dhatariya
    Clinical Therapeutics.2023;[Epub]     CrossRef
  • Corticosteroids for COVID-19: worth it or not?
    Fariya Akter, Yusha Araf, Mohammad Jakir Hosen
    Molecular Biology Reports.2022; 49(1): 567.     CrossRef
  • Evidence-Based Management of Steroid-Induced Hyperglycemia in the Inpatient Setting
    Lauren Longaker, Jennifer N. Clements
    ADCES in Practice.2022; 10(1): 40.     CrossRef
  • Is Methylprednisolone Acetate-Related Insulin Resistance Preventable in Cats?
    Karine Marchioro Leal, Mariana Barcelos Rocha, Fernanda Venzon Varela, Luana Rodrigues, Priscila Viau Furtado, Fernanda Vieira Amorim da Costa, Álan Gomes Pöppl
    Topics in Companion Animal Medicine.2022; 49: 100648.     CrossRef
  • Ac3IV, a V1a and V1b receptor selective vasopressin analogue, protects against hydrocortisone-induced changes in pancreatic islet cell lineage
    Shruti Mohan, Ryan A. Lafferty, Peter R. Flatt, R. Charlotte Moffett, Nigel Irwin
    Peptides.2022; 152: 170772.     CrossRef
  • Hospital management of hyperglycemia in the context of COVID-19: evidence-based clinical considerations
    Thiago Bosco Mendes, Alexandre Barbosa Câmara-de-Souza, Bruno Halpern
    Diabetology & Metabolic Syndrome.2022;[Epub]     CrossRef
  • When therapeutic drugs lead to diabetes
    Bruno Fève, André J. Scheen
    Diabetologia.2022; 65(5): 751.     CrossRef
  • Nutrition implications of intrinsic restrictive lung disease
    Sylvia Rinaldi, Christine Balsillie, Cassandra Truchon, Awatif AL‐Mubarak, Marco Mura, Janet Madill
    Nutrition in Clinical Practice.2022; 37(2): 239.     CrossRef
  • Coinfection by Aspergillus and Mucoraceae Species in Two Cases of Acute Rhinosinusitis as a Complication of COVID-19
    Payam Tabarsi, Somayeh Sharifynia, Mihan Pourabdollah Toutkaboni, Zahra Abtahian, Mohammad Rahdar, Arefeh Sadat Mirahmadian, Atousa Hakamifard, Simone Cesaro
    Case Reports in Medicine.2022; 2022: 1.     CrossRef
  • Case Report: Neratinib Therapy Improves Glycemic Control in a Patient With Type 2 Diabetes and Breast Cancer
    Vasileios Angelis, Stephen R. D. Johnston, Amin Ardestani, Kathrin Maedler
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature
    Victor O. Ukwenya, Sunday A. Adelakun, Temiloluwa A. Fuwape, Ayotunde S. Adeagbo
    Current Diabetes Reviews.2022;[Epub]     CrossRef
  • Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
    Rahul Gupta
    Bulletin of the National Research Centre.2022;[Epub]     CrossRef
  • Circadian clock, diurnal glucose metabolic rhythm, and dawn phenomenon
    Fei Peng, Xin Li, Fang Xiao, Ruxing Zhao, Zheng Sun
    Trends in Neurosciences.2022; 45(6): 471.     CrossRef
  • 3,3′,4,5′-Tetramethoxy-trans-stilbene Improves Insulin Resistance by Activating the IRS/PI3K/Akt Pathway and Inhibiting Oxidative Stress
    Yi Tan, Lingchao Miao, Jianbo Xiao, Wai San Cheang
    Current Issues in Molecular Biology.2022; 44(5): 2175.     CrossRef
  • Management of Glucocorticoid-Induced Hyperglycemia
    Parag Shah, Sanjay Kalra, Yogesh Yadav, Nilakshi Deka, Tejal Lathia, Jubbin Jagan Jacob, Sunil Kumar Kota, Saptarshi Bhattacharya, Sharvil S Gadve, KAV Subramanium, Joe George, Vageesh Iyer, Sujit Chandratreya, Pankaj Kumar Aggrawal, Shailendra Kumar Sing
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1577.     CrossRef
  • Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
    Marcos Tadashi Kakitani Toyoshima, Priscilla Cukier, Alexandre Barbosa Câmara de Souza, Juliana Pereira, Ana Oliveira Hoff, Marcia Nery
    einstein (São Paulo).2022;[Epub]     CrossRef
  • Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
    Rohit Sharma, Praveen Kumar, Abdur Rauf, Ashun Chaudhary, Pradeep Kumar Prajapati, Talha Bin Emran, Clara Mariana Gonçalves Lima, Carlos Adam Conte-Junior
    Frontiers in Cellular and Infection Microbiology.2022;[Epub]     CrossRef
  • Black pepper oil (Piper nigrum L.) mitigates dexamethasone induced pancreatic damage via modulation of oxidative and nitrosative stress
    Mona F. Mahmoud, Asmaa M. Elmaghraby, Noura Ali, Islam Mostafa, Assem M. El-Shazly, Mohamed A.O. Abdelfattah, Mansour Sobeh
    Biomedicine & Pharmacotherapy.2022; 153: 113456.     CrossRef
  • Various Coated Barrier Membranes for Better Guided Bone Regeneration: A Review
    Ji-Youn Kim, Jun-Beom Park
    Coatings.2022; 12(8): 1059.     CrossRef
  • RETROSPECTIVE STUDY ON GLYCAEMIC CONTROL OF THE MIDDLE-AGED PATIENTS RECEIVING STEROID THERAPY IN COVID ICU
    Sayantan Dutta, Sumanta Ghosh Maulik, Jisnu Nayak
    PARIPEX INDIAN JOURNAL OF RESEARCH.2022; : 1.     CrossRef
  • Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy
    Joachim Baech, Marianne Tang Severinsen, Andreas K. Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Jørgensen, Michael Roost Clausen, Christian B. Poulsen, Peter Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström
    Blood Advances.2022; 6(15): 4427.     CrossRef
  • Diabètes pharmaco-induits : quatre classes médicamenteuses au cœur de notre pratique clinique
    André J. Scheen, Bruno Fève
    Médecine des Maladies Métaboliques.2022; 16(7): 627.     CrossRef
  • Dexamethasone-induced derangement in some liver function parameters: Hepatoprotective effect of L-Citrulline
    Timothy Danboyi, Abdulazeez Jimoh, Evelyn Hassan-Danboyi, AbdulWahab Alhassan, AugustineBanlibo Dubo
    Nigerian Journal of Experimental and Clinical Biosciences.2022; 10(3): 74.     CrossRef
  • Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
    Noemí Villén, Albert Roso-Llorach, Carlos Gallego-Moll, Marc Danes-Castells, Sergio Fernández-Bertolin, Amelia Troncoso-Mariño, Monica Monteagudo, Ester Amado, Concepción Violán
    Geriatrics.2022; 7(6): 141.     CrossRef
  • Increased risk of type 2 diabetes in patients with systemic lupus erythematosus: A nationwide cohort study in Taiwan
    Yeong-Jang Lin, Chih-Chiang Chien, Chung-Han Ho, Hung-An Chen, Chao-Yu Chen
    Medicine.2022; 101(51): e32520.     CrossRef
  • Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety
    Angélica María Téllez Arévalo, Abraham Quaye, Luis Carlos Rojas-Rodríguez, Brian D. Poole, Daniela Baracaldo-Santamaría, Claudia M. Tellez Freitas
    Medicina.2022; 59(1): 56.     CrossRef
  • Effect of Ficus lacor Buch. Ham. Fruit Extract on Dexamethasone Induced Insulin Resistant Rats
    V. S. Mule, N. S. Naikwade
    Research Journal of Pharmacy and Technology.2022; : 5559.     CrossRef
  • Prednisolone-induced diabetes mellitus in the cat: a historical cohort
    Sivert Nerhagen, Hanne L Moberg, Gudrun S Boge, Barbara Glanemann
    Journal of Feline Medicine and Surgery.2021; 23(2): 175.     CrossRef
  • Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy
    Mattia Quattrocelli, Aaron S. Zelikovich, Isabella M. Salamone, Julie A. Fischer, Elizabeth M. McNally
    Journal of Neuromuscular Diseases.2021; 8(1): 39.     CrossRef
  • A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetes
    Thomas Forst, Pratik Choudhary, Doron Schneider, Bruno Linetzky, Paolo Pozzilli
    Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
  • Incidence and control of steroid-induced hyperglycaemia in hospitalised patients at a tertiary care centre for lung diseases
    Matej Dobravc Verbič, Jasna Gruban, Mojca Kerec Kos
    Pharmacological Reports.2021; 73(3): 796.     CrossRef
  • Epigenetics in blood–brain barrier disruption
    Stephanie A. Ihezie, Iny Elizebeth Mathew, Devin W. McBride, Ari Dienel, Spiros L. Blackburn, Peeyush Kumar Thankamani Pandit
    Fluids and Barriers of the CNS.2021;[Epub]     CrossRef
  • Risk factors for corticosteroid-induced hyperglycemia requiring insulin therapy in hospitalized patients without diabetes
    Catherine Li, Patricia Krause, Gretchen Stern
    Endocrine.2021; 73(2): 476.     CrossRef
  • Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women
    Wojciech Krzyzanski, Mark A. Milad, Alan H. Jobe, Thomas Peppard, Robert R. Bies, William J. Jusko
    Journal of Pharmacokinetics and Pharmacodynamics.2021; 48(3): 411.     CrossRef
  • Hormonal activity in commonly used Black hair care products: evaluating hormone disruption as a plausible contribution to health disparities
    Tamarra James-Todd, Lisa Connolly, Emma V. Preston, Marlee R. Quinn, Monika Plotan, Yuling Xie, Bharathi Gandi, Shruthi Mahalingaiah
    Journal of Exposure Science & Environmental Epidemiology.2021; 31(3): 476.     CrossRef
  • New‐onset diabetes in “long COVID”
    Thirunavukkarasu Sathish, Mary Chandrika Anton, Tharsan Sivakumar
    Journal of Diabetes.2021; 13(8): 693.     CrossRef
  • Glucocorticoid-Induced Exacerbation of Mycobacterial Infection Is Associated With a Reduced Phagocytic Capacity of Macrophages
    Yufei Xie, Jiajun Xie, Annemarie H. Meijer, Marcel J. M. Schaaf
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Glucocorticoid signaling in pancreatic islets modulates gene regulatory programs and genetic risk of type 2 diabetes
    Anthony Aylward, Mei-Lin Okino, Paola Benaglio, Joshua Chiou, Elisha Beebe, Jose Andres Padilla, Sharlene Diep, Kyle J. Gaulton, Michael L. Stitzel
    PLOS Genetics.2021; 17(5): e1009531.     CrossRef
  • A Practical Guide for the Management of Steroid Induced Hyperglycaemia in the Hospital
    Felix Aberer, Daniel A. Hochfellner, Harald Sourij, Julia K. Mader
    Journal of Clinical Medicine.2021; 10(10): 2154.     CrossRef
  • Combination of Bawang Dayak Extract and Acarbose against Male White Rat Glucose Levels
    Aditya Maulana Perdana Putra, Ratih Pratiwi Sari, Siska Musiam
    Borneo Journal of Pharmacy.2021; 4(2): 84.     CrossRef
  • Role of Gliclazide in safely navigating type 2 diabetes mellitus patients towards euglycemia: Expert opinion from India
    Subhash Wangnoo, M. Shunmugavelu, Sagili Vijaya Bhaskar Reddy, Vijay Negalur, Shreerang Godbole, Vinay K Dhandhania, Nareen Krishna, Kumar Gaurav
    Endocrine and Metabolic Science.2021; 4: 100102.     CrossRef
  • Genome-Wide Differential Methylation Profiles from Two Terpene-Rich Medicinal Plant Extracts Administered in Osteoarthritis Rats
    Younhee Shin, Sathiyamoorthy Subramaniyam, Jin-Mi Chun, Ji-Hyeon Jeon, Ji-Man Hong, Hojin Jung, Boseok Seong, Chul Kim
    Plants.2021; 10(6): 1132.     CrossRef
  • Chronic glucocorticoid treatment induces hepatic lipid accumulation and hyperinsulinaemia in part through actions on AgRP neurons
    Erika Harno, Charlotte Sefton, Jonathan R. Wray, Tiffany-Jayne Allen, Alison Davies, Anthony P. Coll, Anne White
    Scientific Reports.2021;[Epub]     CrossRef
  • Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment
    Filippo Egalini, Mirko Parasiliti Caprino, Giulia Gaggero, Vincenzo Cappiello, Jacopo Giannelli, Ruth Rossetto Giaccherino, Loredana Pagano, Roberta Giordano
    Endocrines.2021; 2(3): 171.     CrossRef
  • Current cancer therapies and their influence on glucose control
    Carly Yim, Kerry Mansell, Nassrein Hussein, Terra Arnason
    World Journal of Diabetes.2021; 12(7): 1010.     CrossRef
  • Immune‐checkpoint inhibitor‐associated diabetes compared to other diabetes types ‐ A prospective, matched control study
    Sascha R. Tittel, Katharina Laubner, Sebastian M. Schmid, Stefan Kress, Sigrun Merger, Wolfram Karges, Frank J. Wosch, Marcus Altmeier, Marianne Pavel, Reinhard W. Holl
    Journal of Diabetes.2021; 13(12): 1007.     CrossRef
  • Connecting the Dots: Interplay of Pathogenic Mechanisms between COVID-19 Disease and Mucormycosis
    Hariprasath Prakash, Anna Skiada, Raees Ahmad Paul, Arunaloke Chakrabarti, Shivaprakash Mandya Rudramurthy
    Journal of Fungi.2021; 7(8): 616.     CrossRef
  • Antioxidant effects of L-citrulline supplementation in high-fat diet- and dexamethasone-induced Type-2 diabetes mellitus in wistar rats (Rattus norvegicus)
    Evelyn Hassan-Danboyi, Abdulazeez Jimoh, Abdulwahab Alhassan, Timothy Danboyi, KabirAhmed Mohammed, AugustineBanlibo Dubo, Jamilu Haruna, BulusBilly Yakubu
    Nigerian Journal of Experimental and Clinical Biosciences.2021; 9(2): 95.     CrossRef
  • ASSESSMENT OF THE POSSIBLE CAUSES OF DIABETES MELLITUS DEVELOPED IN PATIENTS POST COVID-19 TREATMENT IN A TERTIARY CARE HOSPITAL
    KHUJITH RAJUENI, RUTUJA AMBEKAR, HITENDRAPAL SOLANKI, ABDULRAHAMAN ABUBAKAR MOMIN, SUNITA PAWAR
    International Journal of Pharmacy and Pharmaceutical Sciences.2021; : 11.     CrossRef
  • Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion
    Brandon J. Kennedy, Ashley M. Lato, Alexander R. Fisch, Susan J. Burke, Justin K. Kirkland, Carson W. Prevatte, Lee E. Dunlap, Russell T. Smith, Konstantinos D. Vogiatzis, J. Jason Collier, Shawn R. Campagna
    ACS Medicinal Chemistry Letters.2021; 12(10): 1568.     CrossRef
  • Diabetes in COVID-19 patients: challenges and possible management strategies
    Riyan Al Islam Reshad, Sumaiya Hafiz Riana, Mohammad Al-baruni Chowdhury, Abu Tayab Moin, Faruque Miah, Bishajit Sarkar, Nurnabi Azad Jewel
    The Egyptian Journal of Bronchology.2021;[Epub]     CrossRef
  • Excess Body Mass—A Factor Leading to the Deterioration of COVID-19 and Its Complications—A Narrative Review
    Weronika Gryczyńska, Nikita Litvinov, Bezawit Bitew, Zuzanna Bartosz, Weronika Kośmider, Paweł Bogdański, Damian Skrypnik
    Viruses.2021; 13(12): 2427.     CrossRef
  • Risk of Future Type 2 Diabetes Mellitus in Patients Developing Steroid-Induced Hyperglycemia During Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation
    Jagriti Upadhyay, Nitin Trivedi, Amos Lal
    Lung.2020; 198(3): 525.     CrossRef
  • Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion
    Kecheng Zhu, Yumei Zhang, Juan Zhang, Feiye Zhou, Linlin Zhang, Shushu Wang, Qin Zhu, Qianqian Liu, Xiao Wang, Libin Zhou
    Toxicology Letters.2020; 320: 19.     CrossRef
  • Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease
    Mohamad Isam Saeed, Josefin Eklöf, Imane Achir, Pradeesh Sivapalan, Howraman Meteran, Anders Løkke, Tor Biering‐Sørensen, Filip Krag Knop, Jens‐Ulrik Stæhr Jensen
    Diabetes, Obesity and Metabolism.2020; 22(8): 1348.     CrossRef
  • Patterns of Glucose Fluctuation are Challenging in Patients Treated for Non-Hodgkin’s Lymphoma


    Andreja Marić, Tanja Miličević, Jelena Vučak Lončar, Davor Galušić, Maja Radman
    International Journal of General Medicine.2020; Volume 13: 131.     CrossRef
  • Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers
    Lucy A Ochola, David G Nyamu, Eric M Guantai, Irene W Weru
    Journal of Oncology Pharmacy Practice.2020; 26(4): 823.     CrossRef
  • Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with
    Carina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, Tomas Møller Christensen, Thomas Peter Almdal, Ole Snorgaard, Katrine Bagge Hansen, Ulrik Pedersen-Bjergaard, Peter Lommer Kristensen
    BMC Endocrine Disorders.2020;[Epub]     CrossRef
  • Implementation of a Weight-Based Protocol for the Management of Steroid-Induced Hyperglycemia
    Alyson K. Myers, Mahmuda Khan, Sebastian Choi, Patricia Garnica, Guillaume Stoffels, Amanda Lin
    American Journal of Therapeutics.2020; 27(4): e392.     CrossRef
  • The difference between steroid diabetes mellitus and type 2 diabetes mellitus: a whole-body 18F-FDG PET/CT study
    Qingqing Zhao, Jinxin Zhou, Yu Pan, Huijun Ju, Liying Zhu, Yang Liu, Yifan Zhang
    Acta Diabetologica.2020; 57(11): 1383.     CrossRef
  • Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis
    Jianhua Wu, Sarah L Mackie, Mar Pujades-Rodriguez
    BMJ Open Diabetes Research & Care.2020; 8(1): e001220.     CrossRef
  • Diabète et corticoïdes : nouveautés et aspects pratiques
    M. Bastin, F. Andreelli
    La Revue de Médecine Interne.2020; 41(9): 607.     CrossRef
  • Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes
    Janine Alessi, Giovana B. de Oliveira, Beatriz D. Schaan, Gabriela H. Telo
    Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
  • Glycemic Response to Oral Dexamethasone Predicts Incident Prediabetes in Normoglycemic Subjects With Parental Diabetes
    Ebenezer Nyenwe, Deirdre James, Jim Wan, Sam Dagogo-Jack
    Journal of the Endocrine Society.2020;[Epub]     CrossRef
  • Outcomes of Hospitalized Patients with Glucocorticoid-Induced Hyperglycemia—A Retrospective Analysis
    Neele Delfs, Tristan Struja, Sandra Gafner, Thaddaeus Muri, Ciril Baechli, Philipp Schuetz, Beat Mueller, Claudine Angela Blum
    Journal of Clinical Medicine.2020; 9(12): 4079.     CrossRef
  • Incidence of Hyperglycemia/Secondary Diabetes in Women who have Undergone Curative Chemotherapy for Breast Cancer: First Study from India
    Suresh Rao, Krishna Prasad, Soniya Abraham, Thomas George, Supreeth Kakkaje Chandran, Manjeshwar Shrinath Baliga
    South Asian Journal of Cancer.2020; 09(03): 130.     CrossRef
  • Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study
    Imadeldin Elfaki, Rashid Mir, Faisel Mohammed Abu-Duhier, Chandan Kumar Jha, Adel Ibrahim Ahmad Al-Alawy, Abdullatif Taha Babakr, Salem Abd El-Hadi Habib
    Current Drug Metabolism.2020; 21(14): 1152.     CrossRef
  • What is the optimal time for measuring glucose concentration to detect steroid-induced hyperglycemia in patients with rheumatic diseases?
    Güven Barış Cansu, Döndü Üsküdar Cansu, Bengür Taşkıran, Şule Yaşar Bilge, Muzaffer Bilgin, Cengiz Korkmaz
    Clinical Biochemistry.2019; 67: 33.     CrossRef
  • Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
    Yohei Asada, Takeshi Takayanagi, Tsukasa Kawakami, Eisuke Tomatsu, Atsushi Masuda, Yasumasa Yoshino, Sahoko Sekiguchi-Ueda, Megumi Shibata, Tomihiko Ide, Hajime Niimi, Eishin Yaoita, Yusuke Seino, Yoshihisa Sugimura, Atsushi Suzuki
    International Journal of Endocrinology.2019; 2019: 1.     CrossRef
  • Novel aspects of PCSK9 and lipoprotein receptors in renal disease-related dyslipidemia
    Pragyi Shrestha, Bart van de Sluis, Robin P.F. Dullaart, Jacob van den Born
    Cellular Signalling.2019; 55: 53.     CrossRef
  • Understanding the burden of refractory myasthenia gravis
    Christiane Schneider-Gold, Tim Hagenacker, Nico Melzer, Tobias Ruck
    Therapeutic Advances in Neurological Disorders.2019; 12: 175628641983224.     CrossRef
  • Drug-induced diabetes type 2: In silico study involving class B GPCRs
    Dorota Latek, Ewelina Rutkowska, Szymon Niewieczerzal, Judyta Cielecka-Piontek, Arun Shukla
    PLOS ONE.2019; 14(1): e0208892.     CrossRef
  • Periodically repeated rituximab administrations in children with refractory nephrotic syndrome: 2-year multicenter observational study
    Toshiyuki Takahashi, Takayuki Okamoto, Yasuyuki Sato, Takeshi Yamazaki, Asako Hayashi, Hayato Aoyagi, Michihiko Ueno, Norio Kobayashi, Kimiaki Uetake, Masanori Nakanishi, Tadashi Ariga
    Pediatric Nephrology.2019; 34(1): 87.     CrossRef
  • Management of hyperglycaemia in persons with non-insulin-dependent type 2 diabetes mellitus who are started on systemic glucocorticoid therapy: a systematic review
    Milos Tatalovic, Roger Lehmann, Marcus Cheetham, Albina Nowak, Edouard Battegay, Silvana K Rampini
    BMJ Open.2019; 9(5): e028914.     CrossRef
  • The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis
    Panteleimon Pantelidis, Parmenion P. Tsitsopoulos, Eleni Pappa, Elpida Theologou, Nikolaos Karanikolas, Christos Drosos, Christos Tsonidis
    Clinical Neurology and Neurosurgery.2019; 184: 105450.     CrossRef
  • Impact of glucocorticoid treatment before pregnancy on glucose homeostasis of offspring exposed to glucocorticoid in adult life
    Flávia Natividade da Silva, Henver Simionato Brunetta, Maciel Alencar Bruxel, Felipe Azevedo Gomes, Alex Rafacho
    Life Sciences.2019; 237: 116913.     CrossRef
  • One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice
    Susan J. Burke, Heidi M. Batdorf, Tai-Yu Huang, Joseph W. Jackson, Katarina A. Jones, Thomas M. Martin, Kristen E. Rohli, Michael D. Karlstad, Tim E. Sparer, David H. Burk, Shawn R. Campagna, Robert C. Noland, Paul L. Soto, J. Jason Collier
    The Journal of Steroid Biochemistry and Molecular Biology.2019; 195: 105468.     CrossRef
  • Effect of preadmission glucocorticoid therapy on 30-day mortality in critically ill patients: a retrospective study of a mixed ICU population in a tertiary hospital
    Tak Kyu Oh, In-Ae Song, Jae Ho Lee, Cheong Lim, Young-Tae Jeon, Hee-Joon Bae, You Hwan Jo
    Annals of Intensive Care.2019;[Epub]     CrossRef
  • Hospitalization as an Opportunity to Optimize Glycemic Control in Oncology Patients
    Amy Hiestand, James Flory, Ritika Chitkara
    Current Diabetes Reports.2019;[Epub]     CrossRef
  • Corticothérapie prolongée chez une personne âgée et diabète
    J.L. Schlienger
    Médecine des Maladies Métaboliques.2018; 12(7): 599.     CrossRef
  • Activation of nuclear receptor PXR impairs glucose tolerance and dysregulates GLUT2 expression and subcellular localization in liver
    Fatemeh Hassani-Nezhad-Gashti, Jaana Rysä, Outi Kummu, Juha Näpänkangas, Marcin Buler, Mikko Karpale, Janne Hukkanen, Jukka Hakkola
    Biochemical Pharmacology.2018; 148: 253.     CrossRef
  • Diabetes Mellitus Secondary to Cushing’s Disease
    Mattia Barbot, Filippo Ceccato, Carla Scaroni
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • MANAGEMENT OF ENDOCRINE DISEASE: Critical review of the evidence underlying management of glucocorticoid-induced hyperglycaemia
    Anjana Radhakutty, Morton G Burt
    European Journal of Endocrinology.2018; 179(4): R207.     CrossRef
  • Use of parenteral glucocorticoids and the risk of new onset type 2 diabetes mellitus: A case-control study
    Ala Keyany, Johannes T.H. Nielen, Patrick C. Souverein, Frank de Vries, Bart van den Bemt
    Diabetes Research and Clinical Practice.2018; 139: 100.     CrossRef
  • Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion
    Makoto Daimon, Aya Kamba, Hiroshi Murakami, Satoru Mizushiri, Sho Osonoi, Kota Matsuki, Eri Sato, Jutaro Tanabe, Shinobu Takayasu, Yuki Matsuhashi, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Shizuka Kurauchi, Shigeyuki Nakaji
    Scientific Reports.2017;[Epub]     CrossRef
Close layer
Original Article
Clinical Study
Glucose-Dependent Insulinotropic Peptide Level Is Associated with the Development of Type 2 Diabetes Mellitus
Sunghwan Suh, Mi Yeon Kim, Soo Kyoung Kim, Kyu Yeon Hur, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee
Endocrinol Metab. 2016;31(1):134-141.   Published online March 16, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.1.134
  • 3,920 View
  • 44 Download
  • 7 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   
Background

Incretin hormone levels as a predictor of type 2 diabetes mellitus have not been fully investigated. Therefore, we measured incretin hormone levels to examine the relationship between circulating incretin hormones, diabetes, and future diabetes development in this study.

Methods

A nested case-control study was conducted in a Korean cohort. The study included the following two groups: the control group (n=149), the incident diabetes group (n=65). Fasting total glucagon-like peptide-1 (GLP-1) and total glucose-dependent insulinotropic peptide (GIP) levels were measured and compared between these groups.

Results

Fasting total GIP levels were higher in the incident diabetes group than in the control group (32.64±22.68 pmol/L vs. 25.54±18.37 pmol/L, P=0.034). There was no statistically significant difference in fasting total GLP-1 levels between groups (1.14±1.43 pmol/L vs. 1.39±2.13 pmol/L, P=0.199). In multivariate analysis, fasting total GIP levels were associated with an increased risk of diabetes (odds ratio, 1.005; P=0.012) independent of other risk factors.

Conclusion

Fasting total GIP levels may be a risk factor for the development of type 2 diabetes mellitus. This association persisted even after adjusting for other metabolic parameters such as elevated fasting glucose, hemoglobin A1c, and obesity in the pre-diabetic period.

Citations

Citations to this article as recorded by  
  • Mendelian randomization analyses suggest a causal role for circulating GIP and IL-1RA levels in homeostatic model assessment-derived measures of β-cell function and insulin sensitivity in Africans without type 2 diabetes
    Karlijn A. C. Meeks, Amy R. Bentley, Themistocles L. Assimes, Nora Franceschini, Adebowale A. Adeyemo, Charles N. Rotimi, Ayo P. Doumatey
    Genome Medicine.2023;[Epub]     CrossRef
  • Glucose- and Bile Acid-Stimulated Secretion of Gut Hormones in the Isolated Perfused Intestine Is Not Impaired in Diet-Induced Obese Mice
    Jenna E. Hunt, Jens J. Holst, Sara L. Jepsen
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice
    Fei Yang, Shan Dang, Hongjun LV, Bingyin Shi
    Journal of International Medical Research.2021; 49(1): 030006052098566.     CrossRef
  • Elevated levels of fasting serum GIP may be protective factors for diabetic retinopathy in type 2 diabetes mellitus
    LingHong Huang, JingXiong Zhou, Bo Liang, HuiBin Huang, LiangYi Li
    International Journal of Diabetes in Developing Countries.2021; 41(4): 543.     CrossRef
  • Enteroendocrine K and L cells in healthy and type 2 diabetic individuals
    Tina Jorsal, Nicolai A. Rhee, Jens Pedersen, Camilla D. Wahlgren, Brynjulf Mortensen, Sara L. Jepsen, Jacob Jelsing, Louise S. Dalbøge, Peter Vilmann, Hazem Hassan, Jakob W. Hendel, Steen S. Poulsen, Jens J. Holst, Tina Vilsbøll, Filip K. Knop
    Diabetologia.2018; 61(2): 284.     CrossRef
  • Articles inEndocrinology and Metabolismin 2016
    Won-Young Lee
    Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
Close layer
Review Article
Thyroid
Subclinical Hypothyroidism and Cardiovascular Disease
Sunghwan Suh, Duk Kyu Kim
Endocrinol Metab. 2015;30(3):246-251.   Published online August 4, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.3.246
  • 5,300 View
  • 71 Download
  • 31 Web of Science
  • 29 Crossref
AbstractAbstract PDFPubReader   

Subclinical hypothyroidism (SCH) is a common disorder that is characterized by elevated thyroid-stimulating hormone levels in conjunction with free thyroxine concentrations within the normal reference range. Thyroid hormones are known to affect the heart and vasculature and, as a result, the impact of SCH on the cardiovascular (CV) system has recently become an important topic of research. Strong evidence points to a link between SCH and CV risk factors such as alterations in blood pressure, lipid levels, and atherosclerosis. Additionally, accumulating evidence indicates that SCH is associated with metabolic syndrome and heart failure. The present review proposes that SCH may be a potentially modifiable risk factor of CV disease and mortality. However, large-scale clinical trials with appropriate power investigating the risks and benefits of SCH treatment are required to determine whether these benefits can be achieved with levothyroxine therapy.

Citations

Citations to this article as recorded by  
  • Prognostic implications of thyroid disease in patients with atrial fibrillation
    Anthi Vasilopoulou, Vasiliki Patsiou, Alexandra Bekiaridou, Andreas S. Papazoglou, Dimitrios V. Moysidis, Marina Spaho, Martha Zergioti, Dimitrios Kostakakis, Maria-Eirini Kyriakideli, Chrysanthi-Ioanna Lampropoulou, Anastasios Kartas, Athanasios Samaras,
    Heart and Vessels.2024; 39(2): 185.     CrossRef
  • A Comparative Study of Iron Status in Subclinical Hypothyroid and Euthyroid Subjects in a Tertiary Care Hospital
    Thokati G Swapnika, S S Sabitha Rani, Satish Dipankar, Afreen Begum H Itagi, Immadi S Vamshidhar
    Cureus.2024;[Epub]     CrossRef
  • The influence of hypothyroidism on the course of coronary artery disease in patients with reduced left ventricular ejection fraction
    M.V. Kucheriava, G.B. Mankovskyi
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2023; 19(3): 161.     CrossRef
  • Correlation between Subclinical Hypothyroidism and Metabolic Syndrome: A Retrospective Study
    SalhahSaleh Alsulami, Mukhtiar Baig, AtheerHameed Albeladi, ShahadBandar Alyoubi, ShahadAlhumaidi Alsubaie, SamahAbdulsalam Albeladi, KholoudAlawi Ghamri, AbeerMohammed Saeed Alraiqi, SafaMobarak Alyoubi, WesamAied Almutairi
    Saudi Journal of Medicine and Medical Sciences.2023; 11(3): 250.     CrossRef
  • Low awareness and under-diagnosis of hypothyroidism
    Ulrike Gottwald-Hostalek, Barbara Schulte
    Current Medical Research and Opinion.2022; 38(1): 59.     CrossRef
  • Mean platelet volume (MPV) levels in subclinical hypothyroidism and its relation to serum lipid levels
    Zafer ERCAN, Mehmet Emin DEMİR
    Anatolian Current Medical Journal.2022; 4(3): 234.     CrossRef
  • The impact of subclinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention
    Yong-Sheng Liu, Mei Wei, Le Wang, Gang Liu, Guo-Ping Ma, Katsushige Ono, Ze-Long Cao, Man Yang, Ming-Qi Zheng
    BMC Endocrine Disorders.2021;[Epub]     CrossRef
  • Subclinical Hypothyroidism in Geriatric Population and Its Association With Heart Failure
    Priyanka Panday, Ana P Arcia Franchini, Beshoy Iskander, Fatima Anwer, Federico Oliveri, Fotios Kakargias , Pousette Hamid
    Cureus.2021;[Epub]     CrossRef
  • The Effect of Thyroxine Therapy on Cardiovascular Risk Factors in Patients with Subclinical Hypothyroidism
    Selvihan BEYSEL, Mahmut APAYDIN, Mustafa ÇALIŞKAN, Mustafa ÖZBEK, Erman ÇAKAL
    Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi.2021;[Epub]     CrossRef
  • Pathophysiological aspects of development myocardial infarction type 2 in subclinical hypothyroidism
    A. A. Ivannikov, A. A. Kanibolotsky, Kh. G. Alidzhanova, I. V. Bratischev
    Medical alphabet.2021; (42): 34.     CrossRef
  • Unknown Subclinical Hypothyroidism and In-Hospital Outcomes and Short- and Long-Term All-Cause Mortality among ST Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention
    Elena Izkhakov, David Zahler, Keren-Lee Rozenfeld, Dor Ravid, Shmuel Banai, Yan Topilsky, Naftali Stern, Yona Greenman, Yacov Shacham
    Journal of Clinical Medicine.2020; 9(12): 3829.     CrossRef
  • Evaluation of left atrial volume and functions by real time three‐dimensional echocardiography in patients with subclinical hypothyroidism before and after levothyroxine therapy
    Seçkin Dereli, Adil Bayramoğlu, Nurtaç Özer, Ahmet Kaya, Muhammet Özbilen
    Echocardiography.2019; 36(5): 916.     CrossRef
  • The impact of thyroid hormone dysfunction on ischemic heart disease
    Madalena von Hafe, João Sergio Neves, Catarina Vale, Marta Borges-Canha, Adelino Leite-Moreira
    Endocrine Connections.2019; 8(5): R76.     CrossRef
  • Association High-Iodine-Containing Seaweed Soup Consumption after Birth and Subclinical Hypothyroidism in Korean Women: Korea National Health and Nutrition Examination Survey IV (2013–2015)
    Hyunsam Kim, Ha Ni Lee, Jeonghoon Ha
    International Journal of Thyroidology.2019; 12(2): 105.     CrossRef
  • Association between subclinical hypothyroidism and metabolic disorders: A retrospective chart review study in an emerging university hospital
    Khaled Aldossari, Sameer Al‐Ghamdi, Jamaan Al‐Zahrani, Anwar Al Jammah, Bader Alanazi, Abdulilah Al‐Briek, Mohammad Alanazi
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study
    Rasiah Thayakaran, Nicola J Adderley, Christopher Sainsbury, Barbara Torlinska, Kristien Boelaert, Dana Šumilo, Malcolm Price, G Neil Thomas, Konstantinos A Toulis, Krishnarajah Nirantharakumar
    BMJ.2019; : l4892.     CrossRef
  • Visceral Adiposity Index Levels in Patients with Hypothyroidism
    Selma Pekgor, Cevdet Duran, Ruhuşen Kutlu, Ibrahim Solak, Ahmet Pekgor, Mehmet Ali Eryilmaz
    Journal of the National Medical Association.2018; 110(6): 606.     CrossRef
  • Diagnosis and Management of Hypothyroidism: Addressing the Knowledge–Action Gaps
    Sanjay Kalra, A. K. Das, Sarita Bajaj, Banshi Saboo, Deepak Khandelwal, Mangesh Tiwaskar, Navneet Agarwal, Pritam Gupta, Rakesh Sahay, Sameer Aggarwal, Sujoy Ghosh, Vijay Negalur, A. G. Unnikrishnan, Ganapathi Bantwal, Rashmi Aggarwal, Harshal Chaudhari,
    Advances in Therapy.2018; 35(10): 1519.     CrossRef
  • DYNAMICS OF EXCHANGE PARAMETERS OF ULTRASONIC HEART RESEARCH IN PATIENTS WITH CLIMACTERIC SYNDROME ASSOCIATED WITH HYPOTHYROIDISM UNDER THE INFLUENCE OF COMPLEX THERAPY
    M. O. Pavlovska, V. P. Vakaluk, E. I. Deltsova
    World of Medicine and Biology.2018; 14(63): 056.     CrossRef
  • Risk factors for cardiovascular disease in subclinical hypothyroidism
    F. Decandia
    Irish Journal of Medical Science (1971 -).2018; 187(1): 39.     CrossRef
  • New levothyroxine formulation meeting 95–105% specification over the whole shelf-life: results from two pharmacokinetic trials
    Ulrike Gottwald-Hostalek, Wolfgang Uhl, Peter Wolna, George J. Kahaly
    Current Medical Research and Opinion.2017; 33(2): 169.     CrossRef
  • Subclinical thyroid dysfunction and risk of carotid atherosclerosis
    Hosu Kim, Tae Hyuk Kim, Hye In Kim, So Young Park, Young Nam Kim, Seonwoo Kim, Min-Ji Kim, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Yong-Ki Min, Jae Hoon Chung, Mira Kang, Sun Wook Kim, Tatsuo Shimosawa
    PLOS ONE.2017; 12(7): e0182090.     CrossRef
  • Effect of Marijuana Use on Thyroid Function and Autoimmunity
    Sonali Malhotra, Rubina A. Heptulla, Peter Homel, Roja Motaghedi
    Thyroid.2017; 27(2): 167.     CrossRef
  • Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury
    Viswanathan Rajagopalan, Youhua Zhang, Christine Pol, Clifford Costello, Samantha Seitter, Ann Lehto, Olga V. Savinova, Yue-feng Chen, A. Martin Gerdes
    Frontiers in Physiology.2017;[Epub]     CrossRef
  • Myocardial Performance Index for Patients with Overt and Subclinical Hypothyroidism
    Aziz Karabulut, Abdullah Doğan, Alpaslan Kemal Tuzcu
    Medical Science Monitor.2017; 23: 2519.     CrossRef
  • CARDIOVASCULAR MANIFESTATIONS IN PATIENTS OF HYPOTHYROIDISM- RESULTS OF A SINGLE CENTRE STUDY
    Rohit Vasant Deshpande, Swati Harish Sharma, Swapnil Sahebrao Walke, Mayur Ramakrishnarao Hedau, Bharat Sing Rathod, Amol Raghunath Bhore, Hitesh Lotan Mahale
    Journal of Evolution of Medical and Dental Sciences.2017; 6(45): 3514.     CrossRef
  • The Association of Thyroid Hormones and Tsh with the Metabolic Syndrome in Euthyroid Taiwanese Individuals
    Chun-Yuan Huang, Lee-Ching Hwang
    Endocrine Practice.2016; 22(11): 1303.     CrossRef
  • Potential harmful correlation between homocysteine and low-density lipoprotein cholesterol in patients with hypothyroidism
    Xuejie Dong, Zhi Yao, Yanjin Hu, Ning Yang, Xia Gao, Yuan Xu, Guang Wang
    Medicine.2016; 95(29): e4291.     CrossRef
  • Impaired Hemorheological Parameters and Increased Carotid Intima-Media Thickness in Children with Subclinical Hypothyroidism
    Yasemin Isik-Balci, Sebahat Agladioglu, Kadir Agladioglu, Emine Kilic-Toprak, Ozgen Kilic-Erkek, Bayram Ozhan, Aziz Polat, Melek Bor-Kucukatay
    Hormone Research in Paediatrics.2016; 85(4): 250.     CrossRef
Close layer
Editorial
Obesity and Metabolism
Metformin-Associated Lactic Acidosis
Sunghwan Suh
Endocrinol Metab. 2015;30(1):45-46.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.45
  • 3,526 View
  • 46 Download
  • 5 Web of Science
  • 5 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Compuestos bioactivos de canela y su efecto en la disminución del síndrome metabólico: revisión sistemática
    Fernanda Riós, Aurora Quintero, Javier Piloni, Raquel Cariño, Abigail Reyes
    Archivos Latinoamericanos de Nutrición.2023; 73(1): 74.     CrossRef
  • Impacts of metformin on tuberculosis incidence and clinical outcomes in patients with diabetes: a systematic review and meta-analysis
    Meng Zhang, Jian-qing He
    European Journal of Clinical Pharmacology.2020; 76(2): 149.     CrossRef
  • Metformin: A review of its therapeutic efficacy and adverse effects
    Noura T. Shurrab, El-Shaimaa A. Arafa
    Obesity Medicine.2020; 17: 100186.     CrossRef
  • Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
    Eun Young Lee, Sena Hwang, Yong-ho Lee, Seo Hee Lee, Young Mi Lee, Hua Pyong Kang, Eugene Han, Woonhyoung Lee, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Yonsei Medical Journal.2017; 58(2): 312.     CrossRef
  • Metformin associated lactic acidosis (MALA): clinical profiling and management
    Alessandra Moioli, Barbara Maresca, Andrea Manzione, Antonello Maria Napoletano, Daniela Coclite, Nicola Pirozzi, Giorgio Punzo, Paolo Menè
    Journal of Nephrology.2016; 29(6): 783.     CrossRef
Close layer
Original Articles
Obesity and Metabolism
Sex Factors in the Metabolic Syndrome as a Predictor of Cardiovascular Disease
Sunghwan Suh, Jongha Baek, Ji Cheol Bae, Kyoung-Nyoun Kim, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee
Endocrinol Metab. 2014;29(4):522-529.   Published online December 29, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.4.522
  • 4,942 View
  • 37 Download
  • 16 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   
Background

Metabolic syndrome (MetS) is a condition characterized by a cluster of metabolic disorders and is associated with increased risk of cardiovascular disease (CVD). This study analyzed data from the Korean Health and Genome Study to examine the impact of MetS on CVD.

Methods

A total of 8,898 subjects (4,241 males and 4,657 females), 40 to 69 years of age, were enrolled and evaluated for the development of new onset CVD from 2001 to 2012 (median 8.1 years of follow-up).

Results

The prevalence of MetS at baseline was 22.0% (932/4,241) and 29.7% (1,383/4,657) in males and females, respectively. MetS was associated with increased risk of coronary heart disease (CHD; hazard ratio [HR], 1.818; 95% confidence interval [CI], 1.312 to 2.520 in males; HR, 1.789; 95% CI, 1.332 to 2.404 in females) and CVD (HR, 1.689; 95% CI, 1.295 to 2.204 in males; HR, 1.686; 95% CI, 1.007 to 2.192 in females). Specifically, MetS was associated with risk of future stroke in females only (HR, 1.486; 95% CI, 1.007 to 2.192). Among MetS components, abdominal obesity and hypertension were independent predictors of both CHD and CVD. In addition, a higher number of MetS components correlated with higher CVD risk.

Conclusion

MetS is a significant risk factor for the development of CVD although its impact varies between sexes.

Citations

Citations to this article as recorded by  
  • Cardiovascular age of workers with different employment categories
    Byung-Kook Lee, Jaeouk Ahn, Nam-Soo Kim, Jungsun Park, Yangho Kim
    Archives of Environmental & Occupational Health.2022; 77(3): 243.     CrossRef
  • Effects of Anthocyanin-rich Berries on the Risk of Metabolic Syndrome: A Systematic Review and Meta-analysis
    Mikkel Roulund Wilken, Max Norman Tandrup Lambert, Christine Bodelund Christensen, Per Bendix Jeppesen
    Review of Diabetic Studies.2022; 18(1): 42.     CrossRef
  • Rate and risk factors of metabolic components and component combinations according to hypertension status in Tibetans in a cross-sectional study
    Jihong Hu, Brian Thompson, Shuxia Wang, Minhao Guo, Chunjuan Yan, Fengfeng Ding, Peng Guo, Li Chen, Zhuoma Cao, Jianzong Wang
    Medicine.2022; 101(43): e31320.     CrossRef
  • Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study
    Azra Ramezankhani, Fereidoun Azizi, Farzad Hadaegh
    Cardiovascular Diabetology.2022;[Epub]     CrossRef
  • The Association of Metabolic Syndrome with the development of cardiovascular disease among Kazakhs in remote rural areas of Xinjiang, China: a cohort study
    Wenwen Yang, Shuxia Guo, Haixia Wang, Yu Li, Xianghui Zhang, Yunhua Hu, Heng Guo, Kui Wang, Yizhong Yan, Jingyu Zhang, Jiaolong Ma, Lei Mao, Lati Mu, Jiaming Liu, Yanpeng Song, Changjing Li, Zhuo Ma, Rulin Ma, Jia He
    BMC Public Health.2021;[Epub]     CrossRef
  • Serum Arylsulfatase and Acid Phosphatase Activity in Patients with Metabolic Syndrome as a Result of Oxidative Damage to Lysosomes
    Dorota M. Olszewska-Słonina
    Protein & Peptide Letters.2021; 28(11): 1246.     CrossRef
  • Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort
    Jae Hyun Bae, Min Kyong Moon, Sohee Oh, Bo Kyung Koo, Nam Han Cho, Moon-Kyu Lee
    Diabetes & Metabolism Journal.2020; 44(3): 458.     CrossRef
  • The Prevalence of Obesity and Metabolic Syndrome in the Korean Military Compared with the General Population
    Jung Hwan Lee, Da Hea Seo, Min Jung Nam, Geon Hui Lee, Dong Hee Yang, Min Joo Lee, Ung-Rim Choi, Seongbin Hong
    Journal of Korean Medical Science.2018;[Epub]     CrossRef
  • Relationship between serum bilirubin levels and cardiovascular disease
    Sunghwan Suh, Young Rak Cho, Mi Kyoung Park, Duk Kyu Kim, Nam H. Cho, Moon-Kyu Lee, Christian Herder
    PLOS ONE.2018; 13(2): e0193041.     CrossRef
  • Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang
    Wenwen Yang, Rulin Ma, Xianghui Zhang, Heng Guo, Jia He, Lei Mao, Lati Mu, Yunhua Hu, Yizhong Yan, Jiaming Liu, Jiaolong Ma, Shugang Li, Yusong Ding, Mei Zhang, Jingyu Zhang, Shuxia Guo
    Scientific Reports.2018;[Epub]     CrossRef
  • Impact of interactions among metabolic syndrome components on the development of cardiovascular disease among Kazakhs in Xinjiang
    Wenwen Yang, Xiang Gao, Xianghui Zhang, Yunhua Hu, Heng Guo, Kui Wang, Yizhong Yan, Jia He, Jingyu Zhang, Jiaolong Ma, Lei Mao, Lati Mu, Jiaming Liu, Shugang Li, Yusong Ding, Mei Zhang, Rulin Ma, Shuxia Guo, Mahesh Narayan
    PLOS ONE.2018; 13(10): e0205703.     CrossRef
  • Prediction of cardiovascular disease in Korean population: based on health risk appraisal of national health screening program
    Jae Moon Yun, Tae Gon Yoo, Seung-Won Oh, Be Long Cho, Eunyoung Kim, Insob Hwang
    Journal of the Korean Medical Association.2017; 60(9): 746.     CrossRef
  • Metabolic Syndrome Is a Strong Risk Factor for Minor Ischemic Stroke and Subsequent Vascular Events
    Guang-Sheng Wang, Dao-Ming Tong, Xiao-Dong Chen, Tong-Hui Yang, Ye-Ting Zhou, Xiao-Bo Ma, Gianpaolo Reboldi
    PLOS ONE.2016; 11(8): e0156243.     CrossRef
  • Metabolic syndrome related to cardiovascular events in a 10-year prospective study
    Laura Kazlauskienė, Jūratė Butnorienė, Antanas Norkus
    Diabetology & Metabolic Syndrome.2015;[Epub]     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
  • Impact of Cadmium Exposure on the Association between Lipopolysaccharide and Metabolic Syndrome
    Seung Han, Kyoung Ha, Ja Jeon, Hae Kim, Kwan Lee, Dae Kim
    International Journal of Environmental Research and Public Health.2015; 12(9): 11396.     CrossRef
  • Heat Killed Lactobacillus reuteri GMNL-263 Reduces Fibrosis Effects on the Liver and Heart in High Fat Diet-Hamsters via TGF-β Suppression
    Wei-Jen Ting, Wei-Wen Kuo, Dennis Hsieh, Yu-Lan Yeh, Cecilia-Hsuan Day, Ya-Hui Chen, Ray-Jade Chen, Viswanadha Padma, Yi-Hsing Chen, Chih-Yang Huang
    International Journal of Molecular Sciences.2015; 16(10): 25881.     CrossRef
Close layer
Adrenal gland
Clinical Characteristics, Management, and Outcome of 22 Cases of Primary Hypophysitis
Sun Mi Park, Ji Cheol Bae, Ji Young Joung, Yoon Young Cho, Tae Hun Kim, Sang-Man Jin, Sunghwan Suh, Kyu Yeon Hur, Kwang-Won Kim
Endocrinol Metab. 2014;29(4):470-478.   Published online December 29, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.4.470
  • 4,417 View
  • 41 Download
  • 27 Web of Science
  • 24 Crossref
AbstractAbstract PDFPubReader   
Background

Primary hypophysitis causes varying degrees of endocrine dysfunction and mass effect. The natural course and best treatment have not been well established.

Methods

Medical records of 22 patients who had been diagnosed with primary hypophysitis between January 2001 and March 2013 were retrospectively reviewed. Based on the anatomical location, we classified the cases as adenohypophysitis (AH), infundibuloneurohypophysitis (INH), and panhypophysitis (PH). Clinical presentation, endocrine function, pathologic findings, magnetic resonance imaging findings, and treatment courses were reviewed.

Results

Among 22 patients with primary hypophysitis, 81.8% (18/22) had involvement of the posterior pituitary lobe. Two patients of the AH (2/3, 66.6%) and three patients of the PH (3/10, 30%) groups initially underwent surgical mass reduction. Five patients, including three of the PH (3/10, 33.3%) group and one from each of the AH (1/3, 33.3%) and INH (1/9, 11.1%) groups, initially received high-dose glucocorticoid treatment. Nearly all of the patients treated with surgery or high-dose steroid treatment (9/11, 82%) required continuous hormone replacement during the follow-up period. Twelve patients received no treatment for mass reduction due to the absence of acute symptoms and signs related to a compressive mass effect. Most of them (11/12, 92%) did not show disease progression, and three patients recovered partially from hormone deficiency.

Conclusion

Deficits of the posterior pituitary were the most common features in our cases of primary hypophysitis. Pituitary endocrine defects responded less favorably to glucocorticoid treatment and surgery. In the absence of symptoms related to mass effect and with the mild defect of endocrine function, it may not require treatment to reduce mass except hormone replacement.

Citations

Citations to this article as recorded by  
  • Secondary xanthogranulomatous hypophysitis mimicking a pituitary macroadenoma: a case report
    Salma Salhi, Ibtissem Oueslati, Yasmine Mouelhi, Alia Zehani, Nidhameddine Kchir, Elyes Kamoun, Meriem Yazidi, Melika Chihaoui
    Journal of International Medical Research.2024;[Epub]     CrossRef
  • Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis
    Brijesh Krishnappa, Ravikumar Shah, Saba Samad Memon, Chakra Diwaker, Anurag R Lila, Virendra A Patil, Nalini S Shah, Tushar R Bandgar
    Endocrine Connections.2023;[Epub]     CrossRef
  • Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease
    Fabienne Langlois, Elena V Varlamov, Maria Fleseriu
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(1): 10.     CrossRef
  • Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis
    Diane Donegan, Zeb Saeed, Danae A Delivanis, Mohammad Hassan Murad, Juergen Honegger, Felix Amereller, Seda Hanife Oguz, Dana Erickson, Irina Bancos
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(4): 1170.     CrossRef
  • Early Pulse Glucocorticoid Therapy and Improved Hormonal Outcomes in Primary Hypophysitis
    Brijesh Krishnappa, Ravikumar Shah, Vijaya Sarathi, Anurag Ranjan Lila, Manjeet Kaur Sehemby, Virendra A. Patil, Shilpa Sankhe, Nalini Shah, Tushar Bandgar
    Neuroendocrinology.2022; 112(2): 186.     CrossRef
  • Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system
    Kyla Wright, Hyon Kim, Travis Hill, Matthew Lee, Cordelia Orillac, Nikita Mogar, Donato Pacione, Nidhi Agrawal
    Pituitary.2022; 25(4): 602.     CrossRef
  • Hypophysitis
    Diane Donegan, Jürgen Honegger
    Endocrine Practice.2022; 28(9): 901.     CrossRef
  • Rare Case of a Disappearing Pituitary Adenoma During the Coronavirus Disease 2019 (COVID-19) Pandemic
    David P. Bray, C. Arturo Solares, Nelson M. Oyesiku
    World Neurosurgery.2021; 146: 148.     CrossRef
  • Diabetes insipidus secondary to sellar/parasellar lesions
    Anna Angelousi, Chrysoula Mytareli, Paraskevi Xekouki, Eva Kassi, Konstantinos Barkas, Ashley Grossman, Gregory Kaltsas
    Journal of Neuroendocrinology.2021;[Epub]     CrossRef
  • Clinical presentation and management of hypophysitis: An observational study of case series
    Marouan Karrou, Salma Benyakhlef, Achwak Alla, Najoua Messaoudi, Asmae Oulad Amar, Siham Rouf, Imane Kamaoui, Noureddine Oulali, Faycal Moufid, Naima Abda, Hanane Latrech
    Surgical Neurology International.2021; 12: 304.     CrossRef
  • Clinical aspects of autoimmune hypothalamitis, a variant of autoimmune hypophysitis: Experience from one center
    Qian Wei, Guoqing Yang, Zhaohui Lue, Jingtao Dou, Li Zang, Yijun Li, Jin Du, Weijun Gu, Yiming Mu
    Journal of International Medical Research.2020; 48(3): 030006051988783.     CrossRef
  • Primary and Ipilimumab-induced Hypophysitis: A Single-center Case Series
    Paul Atkins, Ehud Ur
    Endocrine Research.2020; 45(4): 246.     CrossRef
  • Hypophysitis (Including IgG4 and Immunotherapy)
    Anna Angelousi, Krystallenia Alexandraki, Marina Tsoli, Gregory Kaltsas, Eva Kassi
    Neuroendocrinology.2020; 110(9-10): 822.     CrossRef
  • Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease
    Leen Wehbeh, Sama Alreddawi, Roberto Salvatori
    Expert Review of Endocrinology & Metabolism.2019; 14(3): 167.     CrossRef
  • Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
    Julie Garon-Czmil, Nadine Petitpain, Franck Rouby, Marion Sassier, Samy Babai, Mélissa Yéléhé-Okouma, Georges Weryha, Marc Klein, Pierre Gillet
    Scientific Reports.2019;[Epub]     CrossRef
  • Clinical Features, Magnetic Resonance Imaging, and Treatment Experience of 20 Patients with Lymphocytic Hypophysitis in a Single Center
    Qiang Zhu, Ke Qian, Guijun Jia, Gang Lv, Jisheng Wang, Liyong Zhong, Shuqing Yu
    World Neurosurgery.2019; 127: e22.     CrossRef
  • Idiopathic granulomatous hypophysitis presenting with galactorrhea, headache, and nausea in a woman: a case report and review of the literature
    Guive Sharifi, Mohammad Reza Mohajeri-Tehrani, Behrouz Navabakhsh, Bagher Larijani, Touraj Valeh
    Journal of Medical Case Reports.2019;[Epub]     CrossRef
  • Paciente de 31 años con polidipsia
    A.R. Benavides Aramburu, M. Seguí Díaz
    Medicina de Familia. SEMERGEN.2018; 44(2): e77.     CrossRef
  • Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions
    Sriram Gubbi, Fady Hannah-Shmouni, Constantine A. Stratakis, Christian A. Koch
    Reviews in Endocrine and Metabolic Disorders.2018; 19(4): 335.     CrossRef
  • Primary lymphocytic hypophysitis: Clinical characteristics and treatment of 50 cases in a single centre in China over 18 years
    Shuchang Wang, Linjie Wang, Yong Yao, Feng Feng, Hongbo Yang, Zhiyong Liang, Kan Deng, Hui You, Jian Sun, Bing Xing, Zimeng Jin, Renzhi Wang, Hui Pan, Huijuan Zhu
    Clinical Endocrinology.2017; 87(2): 177.     CrossRef
  • Clinical presentation and outcome of children with central diabetes insipidus associated with a self‐limited or transient pituitary stalk thickening, diagnosed as infundibuloneurohypophysitis
    J. Schaefers, M. Cools, K. De Waele, I. Gies, V. Beauloye, P. Lysy, I. Francois, D. Beckers, J. De Schepper
    Clinical Endocrinology.2017; 87(2): 171.     CrossRef
  • Intrachiasmatic abscess caused by IgG4-related hypophysitis
    Georgios F. Hadjigeorgiou, Eva Løbner Lund, Lars Poulsgaard, Ulla Feldt-Rasmussen, Åse Krogh Rasmussen, Marianne Wegener, Kåre Fugleholm
    Acta Neurochirurgica.2017; 159(11): 2229.     CrossRef
  • Granulomatous and lymphocytic hypophysitis – are they immunologically distinct?
    Shilpa Rao, Anita Mahadevan, Tanmoy Maiti, Manish Ranjan, Shivayogi Durgad Shwetha, Arimappamagan Arivazhagan, Jitender Saini
    APMIS.2016; 124(12): 1072.     CrossRef
  • Articles in 'Endocrinology and Metabolism' in 2014
    Won-Young Lee
    Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism